{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:59:00Z","timestamp":1778943540163,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health and Family Planning Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.antiviral.2019.104666","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T02:39:42Z","timestamp":1574303982000},"page":"104666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Jun\u00edn virus"],"prefix":"10.1016","volume":"174","author":[{"given":"Xiaoyan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengfu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104666_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00189-18","article-title":"Antibodies to the glycoprotein GP2 subunit cross-react between old and New World arenaviruses","volume":"3","author":"Amanat","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.antiviral.2019.104666_bib2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib3","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-018-04271-z","article-title":"Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses","volume":"9","author":"Clark","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.104666_bib4","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.3390\/v8120332","article-title":"Equine immunoglobulin and equine neutralizing F(ab')(2) protect mice from West Nile virus infection","volume":"8","author":"Cui","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104666_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104666_bib6","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib7","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1128\/JVI.02969-15","article-title":"Glycoprotein-specific antibodies produced by DNA vaccination protect Guinea pigs from lethal Argentine and Venezuelan hemorrhagic fever","volume":"90","author":"Golden","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib8","first-page":"253","article-title":"Arenaviruses","volume":"315","author":"Gonzalez","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.104666_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6981-4_1","article-title":"Global spread of hemorrhagic fever viruses: predicting pandemics","volume":"1604","author":"Gonzalez","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104666_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7774\/cevr.2015.4.1.1","article-title":"Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases","volume":"4","author":"Grunwald","year":"2015","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.antiviral.2019.104666_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004325","article-title":"Development of equine IgG antivenoms against major snake groups in Mozambique","volume":"10","author":"Guidolin","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104666_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0882-4010(90)90010-N","article-title":"Protection of Guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells","volume":"9","author":"Kenyon","year":"1990","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.antiviral.2019.104666_bib13","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1038\/s41598-018-29508-1","article-title":"Neutralization of Junin virus by single domain antibodies targeted against the nucleoprotein","volume":"8","author":"Linero","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104666_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-7-43","article-title":"Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice","volume":"7","author":"Lu","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.antiviral.2019.104666_bib15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1745-7254.2005.00210.x","article-title":"Preparation and development of equine hyperimmune globulin F(ab')2 against severe acute respiratory syndrome coronavirus","volume":"26","author":"Lu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.antiviral.2019.104666_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2015.11.005","article-title":"Molecular basis for antibody-mediated neutralization of New World hemorrhagic fever mammarenaviruses","volume":"18","author":"Mahmutovic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104666_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group","volume":"177","author":"Maiztegui","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104666_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.057000-0","article-title":"Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections","volume":"95","author":"McLay","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","article-title":"Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus","volume":"6","author":"Mehlhop","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104666_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/v4010083","article-title":"The curious case of arenavirus entry, and its inhibition","volume":"4","author":"Nunberg","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104666_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathol-020712-164041","article-title":"Pathogenesis of the viral hemorrhagic fevers","volume":"8","author":"Paessler","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.antiviral.2019.104666_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2018.06.002","article-title":"Novel neutralizing monoclonal antibodies against Junin virus","volume":"156","author":"Pan","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104666_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coviro.2018.11.001","article-title":"Arenavirus genomics: novel insights into viral diversity, origin, and evolution","volume":"34","author":"Pontremoli","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature05539","article-title":"Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses","volume":"446","author":"Radoshitzky","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104666_bib25","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1073\/pnas.0709254105","article-title":"Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses","volume":"105","author":"Radoshitzky","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104666_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004565","article-title":"A simple and novel strategy for the production of a pan-specific antiserum against elapid snakes of Asia","volume":"10","author":"Ratanabanangkoon","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104666_bib27","first-page":"2239","article-title":"Treatment of Argentine hemorrhagic fever with convalescent's plasma. 4433 cases","volume":"15","author":"Ruggiero","year":"1986","journal-title":"Presse Med."},{"key":"10.1016\/j.antiviral.2019.104666_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2019.104666_bib29","article-title":"Equine-origin immunoglobulin fragments protects nonhuman primates from Ebola virus disease","volume":"93","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00954-18","article-title":"Screening and identification of Lassa virus entry inhibitors from an FDA-approved drug library","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104666_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12250-016-3815-4","article-title":"Structure-function relationship of the mammarenavirus envelope glycoprotein","volume":"31","author":"Wang","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.antiviral.2019.104666_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2019.104666_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chom.2017.08.011","article-title":"A potent germline-like human monoclonal antibody targets a pH-sensitive epitope on H7N9 influenza hemagglutinin","volume":"22","author":"Yu","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104666_bib34","first-page":"11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"10","author":"Yu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.104666_bib35","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1073\/pnas.1600996113","article-title":"Monoclonal antibody therapy for Junin virus infection","volume":"113","author":"Zeitlin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104666_bib36","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1073\/pnas.1702127114","article-title":"Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization","volume":"114","author":"Zeltina","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104666_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2016.11.016","article-title":"Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model","volume":"137","author":"Zhao","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104666_bib38","doi-asserted-by":"crossref","first-page":"24179","DOI":"10.1038\/srep24179","article-title":"Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:02Z","timestamp":1759062662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S0166354219304012"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104666","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Jun\u00edn virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104666"}}